Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4861263
Max Phase: Preclinical
Molecular Formula: C86H126N8O8
Molecular Weight: 1400.00
Molecule Type: Unknown
Associated Items:
ID: ALA4861263
Max Phase: Preclinical
Molecular Formula: C86H126N8O8
Molecular Weight: 1400.00
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(CCCCCCCCCCCCCCCCCCCCC(=O)NCCCCCCCCCCC(=O)Nc1ccc2c(c1)[C@@]13CCN4CC5=CCO[C@H]6CC(=O)N2[C@H]1[C@H]6[C@H]5C[C@H]43)NCCCCCCCCCCC(=O)Nc1ccc2c(c1)[C@@]13CCN4CC5=CCO[C@H]6CC(=O)N2[C@H]1[C@H]6[C@H]5C[C@H]43
Standard InChI: InChI=1S/C86H126N8O8/c95-75(87-47-33-27-21-15-13-19-25-31-37-77(97)89-63-39-41-69-67(53-63)85-45-49-91-59-61-43-51-101-71-57-79(99)93(69)83(85)81(71)65(61)55-73(85)91)35-29-23-17-11-9-7-5-3-1-2-4-6-8-10-12-18-24-30-36-76(96)88-48-34-28-22-16-14-20-26-32-38-78(98)90-64-40-42-70-68(54-64)86-46-50-92-60-62-44-52-102-72-58-80(100)94(70)84(86)82(72)66(62)56-74(86)92/h39-44,53-54,65-66,71-74,81-84H,1-38,45-52,55-60H2,(H,87,95)(H,88,96)(H,89,97)(H,90,98)/t65-,66-,71-,72-,73-,74-,81-,82-,83-,84-,85+,86+/m0/s1
Standard InChI Key: JLCIMFIWYBQZMH-GHGDASMBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1400.00 | Molecular Weight (Monoisotopic): 1398.9699 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Zlotos DP, Abdelmalek CM, Botros LS, Banoub MM, Mandour YM, Breitinger U, El Nady A, Breitinger HG, Sotriffer C, Villmann C, Jensen AA, Holzgrabe U.. (2021) C-2-Linked Dimeric Strychnine Analogues as Bivalent Ligands Targeting Glycine Receptors., 84 (2.0): [PMID:33596384] [10.1021/acs.jnatprod.0c01030] |
Source(1):